# OnCo record paper-rtog-0617-lancet-oncol-2015 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-rtog-0617-lancet-oncol-2015/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-rtog-0617-lancet-oncol-2015" ;
  schema:name "Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study"@en ;
  schema:description "Published report from the RTOG 0617 trial registered as NCT00533949, in The Lancet Oncology (2015), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-rtog-0617-lancet-oncol-2015/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s1470-2045(14)71207-0>, <https://pubmed.ncbi.nlm.nih.gov/25601342/>, <https://europepmc.org/article/MED/25601342>, <https://clinicaltrials.gov/study/NCT00533949> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s1470-2045(14)71207-0> ;
  schema:datePublished "2015"^^xsd:gYear ;
  schema:author "Bradley JD, Paulus R, Komaki R, et al." ;
  onco:trials <https://onco.cc/trials/rtog-0617/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .